A report was received on 5 apr 2018 from an intensive care nurse regarding a (b)(6) female with a medical history that included systemic lupus, synovitis and a known hypersensitivity to polysulfone dialyzers, who experienced symptoms while receiving continuous veno-venous hemodialysis (cvvh).The patient was premedicated with intravenous solumedrol/100 and benadryl/50 prior to therapy with the nxstage system one.Two hours after treatment commenced, the patient exhibited hives, rash, respiratory distress, tachypnea with wheezing, increased oxygen requirement and agitation.Treatment was changed to a dialyzer from a different manufacturer and no further issues were reported.
|